7 research outputs found

    MOESM1 of Clinical utility of serum biomarkers in Duchenne muscular dystrophy

    No full text
    Additional file 1: Table S1. List of serum protein biomarkers indentified by mass spectrometry based proteome profiling and SomaScan technique References [44, 45]

    Additional file 1: of Genome-wide association study of lung function and clinical implication in heavy smokers

    No full text
    Table S1. Association Results of the Top SNPs (P < 10− 4) with Post-bronchodilator FEV1/FVC. Table S2. Association Results of the Top SNPs (P < 10− 4) with Post-bronchodilator % Predicted FEV1.Table S3. Genotype Frequency of rs28929474 in SERPINA1 Stratified by GOLD Stages. Table S4. Prediction Models for Post-bronchodilator Lung Function Using Top 10 SNPs for Post-bronchodilator % Predicted FEV1.Figure S1. Joint analysis of the top10 SNPs for post-bronchodilator % predicted FEV1 in 1075 SPIROMICS non-Hispanic White smokers with COPD. (DOCX 141 kb

    Additional file 5: of Elusive sources of variability of dystrophin rescue by exon skipping

    No full text
    Dystrophin protein expression detected by IF and WB after 7 days of PMO delivery. Four mice were treated with one high dose of PMO (800 mg/kg) and sacrificed at 7 days. Tibialis anterior muscles were dissected and analyzed by IF and WB. We observed low levels of dystrophin protein by both quantification methods as compared to saline-treated mice. (PDF 265 kb
    corecore